{
  "query": "analysis subgroup time cause",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT06330480",
          "briefTitle": "Check@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-11-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Atrial Fibrillation", "Chronic Kidney Diseases", "Diabetes Mellitus, Type 2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 320000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05900284",
          "briefTitle": "Safety and Feasibility of Metformin for Sepsis Induced AKI"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Sepsis", "Septic Shock", "Acute Kidney Injury", "Metformin"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02809053",
          "briefTitle": "A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Follicular"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 315,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01250119",
          "briefTitle": "A Study to Assess the Incidence of EGFR Mutation in Patients With Newly Diagnosed Locally Advanced or Metastatic Non-Small Cell Lung Cancer in the UK, And of Tarceva (Erlotinib) as First-Line Therapy in EGFR Mutation Positive Patients."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03"
          },
          "completionDateStruct": {
            "date": "2014-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Squamous Non-Small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 688,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00191477",
          "briefTitle": "Instillation of Gemcitabine in Patients With Superficial Bladder Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-01"
          },
          "completionDateStruct": {
            "date": "2008-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Bladder Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 355,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01678430",
          "briefTitle": "A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-12"
          },
          "completionDateStruct": {
            "date": "2017-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Lymphocytic Leukaemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 670,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01767467",
          "briefTitle": "Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-03-01"
          },
          "completionDateStruct": {
            "date": "2017-01-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 568,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07179445",
          "briefTitle": "Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "NSCLC"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03310957",
          "briefTitle": "Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Triple Negative Breast Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 185,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04781881",
          "briefTitle": "Special Drug Use Surveillance for Entresto Tablets"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Heart Failure"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 688,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02774382",
          "briefTitle": "Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Clostridium Difficile"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 450,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06692556",
          "briefTitle": "Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cutaneous Squamous Cell Carcinoma (CSCC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 266,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04560673",
          "briefTitle": "Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chemotherapy-Induced Peripheral Neuropathy", "Hematopoietic and Lymphoid Cell Neoplasm", "Malignant Solid Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 380,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04238637",
          "briefTitle": "Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Intrahepatic Cholangiocarcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02588612",
          "briefTitle": "Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04587882",
          "briefTitle": "Virtual AppLication-supported ENvironment To INcrease Exercise During Cardiac Rehabilitation Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Heart Diseases", "Cardiovascular Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 223,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07087561",
          "briefTitle": "Short-Term Nutritional Enhancement Combined With Health Education in Postoperative Colorectal Cancer Patients: A Randomized Controlled Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-10-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Colorectal Cancer (Diagnosis)", "Malnutrition or Risk of Malnutrition"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 360,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06896162",
          "briefTitle": "PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Solid Tumor Malignancies", "Metastatic Cancer", "Breast Cancer", "Colorectal Cancer", "Lung Cancer", "Bladder Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04275856",
          "briefTitle": "Etiology, Incidence and Survival of Pediatric Out-of-hospital Cardiac Arrests: a Four-year Danish Analysis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Out-Of-Hospital Cardiac Arrest", "Pediatric Disorder", "Cardiopulmonary Arrest"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00076011",
          "briefTitle": "Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-10"
          },
          "completionDateStruct": {
            "date": "2007-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01262014",
          "briefTitle": "Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-12"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Platinum-resistant Advanced Ovarian Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00089648",
          "briefTitle": "SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-12"
          },
          "completionDateStruct": {
            "date": "2008-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Renal Cell"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 61,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05487716",
          "briefTitle": "HIIT Effects on Long-term Survival in Heart Failure Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-05-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Morality", "Remodeling, Ventricular", "Heart Failure"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 214,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03586011",
          "briefTitle": "Predictors of Increased Physical Activity in Patients Receiving Physical Activity on Prescription"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Health Behavior", "Physical Activity", "Metabolic Syndrome X", "Primary Health Care"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 444,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "27 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03244475",
          "briefTitle": "Transcranial Electrical Stimulation for mTBI"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Mild Traumatic Brain Injury (mTBI)", "Post-traumatic Stress Disorder"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01970865",
          "briefTitle": "A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 364,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04595565",
          "briefTitle": "Sacituzumab Govitecan in Primary HER2-negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["HER2-negative Breast Cancer", "Triple Negative Breast Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1332,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05387473",
          "briefTitle": "Added Value of Cognitive Behavioural Therapy for Insomnia in Persons With Knee Osteoarthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Osteoarthritis, Knee", "Insomnia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 128,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01251588",
          "briefTitle": "Extension Study for Participants of MACI00206 Study of MACI® for the Treatment of Symptomatic Articular Cartilage Defects of the Knee"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-12"
          },
          "completionDateStruct": {
            "date": "2015-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Articular Cartilage Defects"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 128,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05308966",
          "briefTitle": "Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Malignant Pleural Mesothelioma", "Unresectable Malignant Neoplasm"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 204,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04880694",
          "briefTitle": "A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Severe COVID-19 Pneumonia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03871257",
          "briefTitle": "A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Low Grade Glioma", "Neurofibromatosis Type 1", "Visual Pathway Glioma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 165,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06430983",
          "briefTitle": "Recurrent Liver Cancer: Reconceptualization and Reevaluation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Liver Cancer", "Primary Liver Cancer"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07191405",
          "briefTitle": "Clinical Study of Chemotherapy and Immunotherapy Combined With Lactobacillus Johnsonii in Patients With Multiple Irresectable Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-18",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Immunotherapy", "Chemotherapy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 156,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01280747",
          "briefTitle": "Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-01"
          },
          "completionDateStruct": {
            "date": "2012-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Fibromyalgia", "Painful Diabetic Peripheral Neuropathy"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06856148",
          "briefTitle": "Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Substance Abuse", "Substance Use Disorders", "Prevention", "Legislation", "Use of Research Evidence"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02474355",
          "briefTitle": "Real World Treatment Study of AZD9291 for Advanced/Metastatic EGFR T790M Mutation NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-04-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3017,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "130 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02034110",
          "briefTitle": "Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 206,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05036291",
          "briefTitle": "A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Solid Tumor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00603525",
          "briefTitle": "Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-01"
          },
          "completionDateStruct": {
            "date": "2013-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 169,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05447858",
          "briefTitle": "Systematic Work Environment Model Incorporating Web-based Neck-specific Exercise for Dental Staff With Neck Pain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-09",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Workplace", "Neck Pain", "Exercise"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04189809",
          "briefTitle": "Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and Recommendations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatocellular Carcinoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06238843",
          "briefTitle": "A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 450,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06746116",
          "briefTitle": "A Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced or Recurrent Endometrial Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "130 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01282424",
          "briefTitle": "Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Follicular Lymphoma", "Small Lymphocytic Lymphoma", "Lymphoplasmacytic Lymphoma", "Marginal Zone Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 125,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03205761",
          "briefTitle": "Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05568472",
          "briefTitle": "Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Anatomic Stage I Breast Cancer AJCC v8", "Anatomic Stage II Breast Cancer AJCC v8", "Anatomic Stage III Breast Cancer AJCC v8", "Hormone Receptor-Positive Breast Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 565,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04841642",
          "briefTitle": "Feasibility and Impact of a Tele-rehabilitation Program in Patients With Chronic and Non-specific Neck Pain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Non-specific Neck Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02345161",
          "briefTitle": "A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01-23"
          },
          "completionDateStruct": {
            "date": "2016-04-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Disease, Chronic Obstructive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1811,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01878617",
          "briefTitle": "A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-10-13",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Medulloblastoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 660,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "39 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00089076",
          "briefTitle": "MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-06"
          },
          "completionDateStruct": {
            "date": "2009-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adult Grade III Lymphomatoid Granulomatosis", "B-cell Chronic Lymphocytic Leukemia", "Cutaneous B-cell Non-Hodgkin Lymphoma", "Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue", "Intraocular Lymphoma", "Nodal Marginal Zone B-cell Lymphoma", "Recurrent Adult Burkitt Lymphoma", "Recurrent Adult Diffuse Large Cell Lymphoma", "Recurrent Adult Diffuse Mixed Cell Lymphoma", "Recurrent Adult Diffuse Small Cleaved Cell Lymphoma", "Recurrent Adult Grade III Lymphomatoid Granulomatosis", "Recurrent Adult Hodgkin Lymphoma", "Recurrent Adult Immunoblastic Large Cell Lymphoma", "Recurrent Adult Lymphoblastic Lymphoma", "Recurrent Grade 1 Follicular Lymphoma", "Recurrent Grade 2 Follicular Lymphoma", "Recurrent Mantle Cell Lymphoma", "Recurrent Marginal Zone Lymphoma", "Refractory Hairy Cell Leukemia", "Small Intestine Lymphoma", "Splenic Marginal Zone Lymphoma", "Testicular Lymphoma", "Waldenström Macroglobulinemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06723275",
          "briefTitle": "LEOPARD Prospective Validation Cohort 1"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Decompensated Liver Cirrhosis", "Primary Biliary Cholangitis", "Primary Sclerosing Cholangitis", "Hepato-cellular Carcinoma"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 630,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05943990",
          "briefTitle": "Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04915248",
          "briefTitle": "Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Plasmablastic Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04164810",
          "briefTitle": "Effects of Hydrotherapy on Neuropathic Pain and Pain Catastrophization in Spinal Cord Injury"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Neuropathic Pain", "Spinal Cord Injuries"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03737110",
          "briefTitle": "Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Recurrent Pericarditis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 86,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03697824",
          "briefTitle": "Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-25",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-07-18",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "10 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05098405",
          "briefTitle": "First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Malignant Solid Tumor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06048705",
          "briefTitle": "Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03999788",
          "briefTitle": "miR-142-3p as Potential Biomarker of Synaptopathy in MS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Multiple Sclerosis", "Spasticity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05313503",
          "briefTitle": "KETOMIGRAINE: Ketogenic Diet in Drug-resistant Chronic Migraineurs"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Migraine, Headache"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03837977",
          "briefTitle": "Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-11-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Oncology", "Neuroendocrine Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 58,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00794014",
          "briefTitle": "Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-11"
          },
          "completionDateStruct": {
            "date": "2012-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Coronary Artery Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 258,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06094244",
          "briefTitle": "Statins in Patients With Spontaneous Intracerebral Hemorrhage"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Intracerebral Hemorrhage"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 153,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "36 Years",
          "maximumAge": "95 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03598257",
          "briefTitle": "Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Inflammatory Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06644144",
          "briefTitle": "P4O2 ILD Extension"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Interstitial Lung Disease", "Pulmonary Fibrosis", "Interstitial Lung Fibrosis", "IPF", "Pulmonary Fibrosis, Idiopathic", "Pulmonary Fibrosis Idiopathic Familial", "Chronic Hypersensitivity Pneumonitis", "Unclassifiable ILD", "Idiopathic NSIP", "CTD-ILD"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 450,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05614271",
          "briefTitle": "Chronic Postsurgical Pain, Postoperative Cognitive Dysfunction and Resilience"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Postoperative Cognitive Dysfunction", "Chronic Post Operative Pain", "Satisfaction, Patient", "Coping Behavior"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02150967",
          "briefTitle": "A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Cholangiocarcinoma", "FGFR2 Gene Mutation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 143,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06552234",
          "briefTitle": "Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["NSCLC Stage IV", "NSCLC, Stage III"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03981107",
          "briefTitle": "Compression Only CPR Versus Standard CPR in Out-Of-Hospital Cardiac Arrest - A Randomized Survival Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Out-Of-Hospital Cardiac Arrest", "Cardiac Arrest", "Cardiopulmonary Resuscitation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3260,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01743755",
          "briefTitle": "Santeon-CAP; Dexamethasone in Community-acquired Pneumonia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-12"
          },
          "completionDateStruct": {
            "date": "2018-09-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Community-acquired Pneumonia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 413,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03063203",
          "briefTitle": "Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Acute Myeloid Leukemia, Relapsed, Adult"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03931083",
          "briefTitle": "Screening Test Accuracy of Gynocular™, HR-HPV Testing, VIA for Detection of Cervical Neoplastic Lesions, in Women Living With HIV"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Uterine Cervical Neoplasms", "HIV/AIDS"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 450,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05443854",
          "briefTitle": "Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Sepsis", "Septic Shock", "Hematologic Malignancy", "Tumor", "Allogeneic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 340,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04119713",
          "briefTitle": "Autoimmunity After Checkpoint Blockade"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-02-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Autoimmunity", "Cancer", "Immunotoxicity", "Oncology"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05011188",
          "briefTitle": "FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Castration-resistant Prostate Cancer", "Prostate Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01268566",
          "briefTitle": "A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-01"
          },
          "completionDateStruct": {
            "date": "2012-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Glioblastoma Multiforme"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "95 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05158829",
          "briefTitle": "COVID-19 Antibody Responses In Cystic Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 250,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00122681",
          "briefTitle": "Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-05-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2009-11-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infections, Papillomavirus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18729,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "15 Years",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01760876",
          "briefTitle": "Evaluation of HealinG of Polymer-Free Biomlimus A9-Coated Stent by Optical Coherence Tomography (EGO-BIOFREEDOM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-12"
          },
          "completionDateStruct": {
            "date": "2015-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Coronary Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 106,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04746183",
          "briefTitle": "AGILE (Early Phase Platform Trial for COVID-19)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Covid19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 600,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06029270",
          "briefTitle": "Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-04-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Nasopharyngeal Carcinoma", "Recurrent Nasopharyngeal Carcinoma", "Stage IV Nasopharyngeal Carcinoma AJCC v8"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 156,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03691441",
          "briefTitle": "Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Oropharyngeal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 280,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04264845",
          "briefTitle": "Patient-Reported Outcomes as an Indicator of Disease Transitions in Heart Failure"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Heart Failure"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 3640,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02962102",
          "briefTitle": "Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Critically Ill", "Acute Kidney Injury"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05219435",
          "briefTitle": "Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Urothelial Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01602380",
          "briefTitle": "A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-10-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hormone Receptor Positive Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 462,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "130 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03554473",
          "briefTitle": "M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Carcinoma, Small Cell", "Lung Cancer", "Small Cell Lung Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02912624",
          "briefTitle": "Simple Intensive Care Studies I (SICS-I)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-11-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Critical Illness", "Acute Disease", "Shock"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1090,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01835054",
          "briefTitle": "Determinants of the Progression and Outcome of Mitral Regurgitation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-12"
          },
          "completionDateStruct": {
            "date": "2024-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Mitral Valve Insufficiency"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 440,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04402788",
          "briefTitle": "Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Extensive Stage Lung Small Cell Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 138,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06140225",
          "briefTitle": "Adolescents' Health Through Mobile Apps, Wearables, and a Gamified TAC ( ActivA-App )"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Adolescent Behavior", "Physical Activity", "New Technologies"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 480,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06444776",
          "briefTitle": "Therapy-Associated Saliva and Taste Change Evaluation (TASTE) in Head & Neck Cancer Patients Undergoing Radiotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Head and Neck Cancer"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04583462",
          "briefTitle": "Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Type 1 Diabetes", "Peripheral Arterial Calcification"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 230,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00083889",
          "briefTitle": "SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-08"
          },
          "completionDateStruct": {
            "date": "2008-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Renal Cell"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 750,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03941860",
          "briefTitle": "Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05056090",
          "briefTitle": "Effect of Prone Positioning on Mortality in Patients With Mild to Moderate Acute Respiratory Distress Syndrome."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["ARDS", "Acute Respiratory Distress Syndrome", "Intensive Care Unit", "Mechanical Ventilation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 656,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01161160",
          "briefTitle": "Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-07-01"
          },
          "completionDateStruct": {
            "date": "2011-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 209,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "9 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03701308",
          "briefTitle": "Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 264,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05268510",
          "briefTitle": "Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib As Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Esophagogastric Adenocarcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT02576990",
          "briefTitle": "Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Mediastinal Large B-cell Lymphoma", "Richter Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05275010",
          "briefTitle": "A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy Male Subjects"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 151,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06848660",
          "briefTitle": "Study on Orthosis in Cervical Spine Fracture Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cervical Spine Fractures", "Cervical Spine Injury", "Rigid Collar"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 616,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02303717",
          "briefTitle": "Xience Versus Synergy in Left Main PCI"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12"
          },
          "completionDateStruct": {
            "date": "2020-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Coronary Artery Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 818,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03720041",
          "briefTitle": "Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 740,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02299375",
          "briefTitle": "Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Disease, Chronic Obstructive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 184,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01915498",
          "briefTitle": "Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-08-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 345,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00678886",
          "briefTitle": "Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-07-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type 1"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 272,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00867269",
          "briefTitle": "Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-07-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Idiopathic CD4+ Lymphocytopenia", "Cryptococcal Meningitis", "Warts"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 950,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02402062",
          "briefTitle": "A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-05-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Neuroendocrine Tumors", "Pancreatic Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04501159",
          "briefTitle": "pH, Hypoxia and Haemodialysis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "End Stage Renal Disease on Dialysis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03960580",
          "briefTitle": "Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-05-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Rhinosinusitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 223,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01244958",
          "briefTitle": "Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08"
          },
          "completionDateStruct": {
            "date": "2015-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 156,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05012306",
          "briefTitle": "Covid-19 Antibody Responses in Cystic Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04420221",
          "briefTitle": "Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infections, Soft Tissue"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 226,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03563183",
          "briefTitle": "A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 26976,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01288560",
          "briefTitle": "IMAGE-HF Project I-A: Cardiac Imaging in Ischemic Heart Failure (AIMI-HF)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Heart Failure", "Coronary Artery Disease", "Ischemic Cardiomyopathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1390,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01037127",
          "briefTitle": "Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF Inhibitor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-11"
          },
          "completionDateStruct": {
            "date": "2013-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 97,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01921127",
          "briefTitle": "Comparative Effectiveness of Symbicort vs. Advair Among COPD Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-08"
          },
          "completionDateStruct": {
            "date": "2014-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COPD"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 3000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06515184",
          "briefTitle": "Coenzyme Q10 for Gulf War Illness: A Replication Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Gulf War Syndrome", "Persian Gulf Syndrome", "Mitochondrial Disorder, Respiratory Chain"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 192,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04634552",
          "briefTitle": "A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hematological Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 510,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02051608",
          "briefTitle": "A Study of Gantenerumab in Participants With Mild Alzheimer Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Alzheimer's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 389,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03285191",
          "briefTitle": "Subject Insights to Understand Rheumatoid Arthritis (RA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-08-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07071103",
          "briefTitle": "Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Radiotherapy", "Metastatic Solid Cancers", "Immune Checkpoint Blockade", "Esophageal Neoplasms Malignant", "Lung Neoplasm Malignant", "Drug Resistance"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00857194",
          "briefTitle": "Cardiovascular Disease Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-06-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Spinal Cord Injury"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 170,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00265317",
          "briefTitle": "A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-06"
          },
          "completionDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Non-Small-Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 162,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03130790",
          "briefTitle": "Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Gastric Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05327686",
          "briefTitle": "Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-06-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Renal Cell Carcinoma", "Stage III Renal Cell Cancer AJCC v8", "Stage IV Renal Cell Cancer AJCC v8", "Unresectable Renal Cell Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 240,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03041311",
          "briefTitle": "Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 107,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05776511",
          "briefTitle": "Diagnostic Value of eVOG"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Multiple Sclerosis", "Radiologically Isolated Syndrome", "White Matter Lesions"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00085735",
          "briefTitle": "Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-04-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Medulloblastoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 549,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01852799",
          "briefTitle": "A Study of PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-12"
          },
          "completionDateStruct": {
            "date": "2017-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05745350",
          "briefTitle": "First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Small Cell Lung Cancer Extensive Stage"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01396148",
          "briefTitle": "A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Gastrointestinal Stromal Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02207816",
          "briefTitle": "An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-09-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malaria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3084,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "42 Months",
          "maximumAge": "9 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01626079",
          "briefTitle": "Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Mitral Regurgitation", "Mitral Valve Regurgitation", "Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects", "Heart Failure"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 776,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06057246",
          "briefTitle": "Individual Determinants of Postprandial Glucose Response in Type 2 Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 144,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00099437",
          "briefTitle": "Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-02-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 736,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "45 Years",
          "maximumAge": "130 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00219557",
          "briefTitle": "AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-07-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2008-03-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pancreatic Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 111,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04236037",
          "briefTitle": "Ultrasound-guided Biopsy of the Pleura as a Supplement to Extraction of Fluid in Patients With One-sided Fluid in the Pleura"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-09-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Malignant Pleural Effusion", "Exudative Pleural Effusion"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04624581",
          "briefTitle": "FIbromyalgia anD GenetIcs Subgroups (FIDGIS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Fibromyalgia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 260,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06955442",
          "briefTitle": "Racial Disparities in Acute Stroke"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-01-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ischemic Stroke"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 4500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01826994",
          "briefTitle": "Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-09"
          },
          "completionDateStruct": {
            "date": "2016-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Coronary Syndrome", "Angina Pectoris, Unstable", "Angina Pectoris, Stable", "Thoracic Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 303,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05631379",
          "briefTitle": "Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Retroperitoneal Sarcoma", "Body Composition", "Malnutrition", "Sarcopenia", "Sarcopenic Obesity", "Myosteatosis"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00066742",
          "briefTitle": "Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-09"
          },
          "completionDateStruct": {
            "date": "2009-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Limited Stage Small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02362594",
          "briefTitle": "Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-11-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1019,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03377556",
          "briefTitle": "Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["ATM Gene Mutation", "ATR Gene Mutation", "BARD1 Gene Mutation", "BRCA1 Gene Mutation", "BRCA2 Gene Mutation", "BRIP1 Gene Mutation", "CHEK1 Gene Mutation", "CHEK2 Gene Mutation", "FANCA Gene Mutation", "FANCC Gene Mutation", "FANCD2 Gene Mutation", "FANCF Gene Mutation", "FANCM Gene Mutation", "NBN Gene Mutation", "PALB2 Gene Mutation", "RAD51 Gene Mutation", "RAD51B Gene Mutation", "RAD54L Gene Mutation", "Recurrent Squamous Cell Lung Carcinoma", "RPA1 Gene Mutation", "Stage IV Squamous Cell Lung Carcinoma AJCC v7"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02328105",
          "briefTitle": "LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12"
          },
          "completionDateStruct": {
            "date": "2019-12-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02978300",
          "briefTitle": "HFNC Alone or Associated With NIV for Immunocompromised Patients Admitted to ICU for Acute Respiratory Failure"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-08-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Respiratory Failure", "Immunosuppression"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02642419",
          "briefTitle": "Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01"
          },
          "completionDateStruct": {
            "date": "2017-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atrial Fibrillation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03297593",
          "briefTitle": "Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Cell Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 74,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04486313",
          "briefTitle": "Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-02-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 935,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04983095",
          "briefTitle": "Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2033-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancer Metastatic", "Radiation Therapy", "Positron-Emission Tomography"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 118,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05453461",
          "briefTitle": "ADVANCED FSHD-COM: New Clinical Outcome Measures to Evaluate Non-ambulant FSHD Patients, a Pilot Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Facioscapulohumeral Muscular Dystrophy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01949194",
          "briefTitle": "Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07236320",
          "briefTitle": "Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Esophageal Squamous Cell Carcinoma (ESCC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02733198",
          "briefTitle": "Prognostication in Acute Pulmonary Embolism"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Embolism"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05320263",
          "briefTitle": "Contact Aspiration Versus Stent Retriever for Recanalisation of Acute Stroke Patients With Basilar Artery Occlusion: The Posterior Circulation ASTER Randomized Trial Protocol"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Basilar Artery Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 480,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06003621",
          "briefTitle": "Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-11-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Solid Tumor, Adult"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 96,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06148012",
          "briefTitle": "Investigation Of Marginal Bone Loss In Implants With Different Surface Properties And Geometric Designs: A Retrospective Clinical Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Implant Infection", "Peri-Implantitis", "Bone Loss"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04460521",
          "briefTitle": "The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Carpal Tunnel Syndrome", "Hand Injuries and Disorders", "Nerve Compression", "Splints", "Carpal Tunnel", "Carpal Tunnel Release"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 240,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03004521",
          "briefTitle": "Lithium Versus Quetiapine in Treatment Resistant Depression"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Depressive Disorder, Treatment-Resistant"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 276,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06055881",
          "briefTitle": "Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Breast Carcinoma", "Anatomic Stage IV Breast Cancer AJCC v8", "Metastatic Breast Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03955471",
          "briefTitle": "Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ovarian Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01398085",
          "briefTitle": "IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-05"
          },
          "completionDateStruct": {
            "date": "2031-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Thyroid Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 504,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07148245",
          "briefTitle": "Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cutaneous Melanoma", "Cutaneous Melanoma, Stage III", "Cutaneous Melanoma by AJCC V7 Stage", "Cutaneous Melanoma, Stage IV"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00509899",
          "briefTitle": "Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-06"
          },
          "completionDateStruct": {
            "date": "2017-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myelofibrosis", "Polycythemia Vera", "Thrombocytosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 154,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01841736",
          "briefTitle": "Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-09-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Foregut Neuroendocrine Tumor", "Hindgut Neuroendocrine Tumor", "Metastatic Digestive System Neuroendocrine Tumor G1", "Metastatic Neuroendocrine Tumor", "Midgut Neuroendocrine Tumor G1", "Neuroendocrine Tumor G2", "Recurrent Digestive System Neuroendocrine Tumor G1", "Regional Digestive System Neuroendocrine Tumor G1"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 171,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00867048",
          "briefTitle": "Strategic Timing of Antiretroviral Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-04-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4688,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02785939",
          "briefTitle": "Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["CCND1 Gene Amplification", "CCND2 Gene Amplification", "CCND3 Gene Amplification", "CDK4 Gene Amplification", "Recurrent Squamous Cell Lung Carcinoma", "Stage IV Squamous Cell Lung Carcinoma AJCC v7"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 53,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04063332",
          "briefTitle": "Functionality of Endogenous Biological Clock in Sepsis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Circadian Rhythm Disorders", "Sepsis"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05029206",
          "briefTitle": "Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Multiple Sclerosis", "Multiple Sclerosis, Relapsing-Remitting"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 174,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03781804",
          "briefTitle": "Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Rhinosinusitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 332,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00558896",
          "briefTitle": "CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma and Plasma Cell Neoplasm"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 378,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00267098",
          "briefTitle": "Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-12"
          },
          "completionDateStruct": {
            "date": "2013-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Atrioventricular Block", "Heart Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 918,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06701084",
          "briefTitle": "Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Neonatal Epilepsy", "Infantile Epilepsy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 600,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05621434",
          "briefTitle": "A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-12-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "HER2-positive Recurrent/Metastatic Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 63,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04153149",
          "briefTitle": "HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Transthyretin Amyloidosis (ATTR) With Cardiomyopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 655,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02180906",
          "briefTitle": "Biomarkers in Patients With Flesh-eating Bacterial Infections"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-02"
          },
          "completionDateStruct": {
            "date": "2016-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Necrotizing Soft Tissue Infection", "Necrotizing Fasciitis", "Gas Gangrene", "Fournier Gangrene"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 169,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04246489",
          "briefTitle": "Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Uterine Cervical Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 146,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03857633",
          "briefTitle": "MRI Assessment of Myocardial Fibrosis Associated With Monocyte Phenotype in End Stage Renal Failure"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myocardial Fibrosis", "End Stage Renal Failure on Dialysis", "Chronic Kidney Disease, Stage IV (Severe)", "Chronic Kidney Disease Stage V", "Heart Failure"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04581252",
          "briefTitle": "Heart Failure HemOdynamic Prognostic Evaluation and OutcomE (HF-HOPE) Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Heart Failure"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05105360",
          "briefTitle": "Prevention of Petersen's Hernia After Laparoscopic Gastrectomy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-01-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Petersen's Hernia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 444,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07147517",
          "briefTitle": "Preparedness Through Respiratory Virus Epidemiology and Community Engagement"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-10-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Respiratory Infection Virus", "COVID -19", "RSV", "FLU"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 25000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02917460",
          "briefTitle": "Rady Children's Institute Genomic Biorepository"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2050-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Genetic Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 102000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03460613",
          "briefTitle": "Prevalence of FODMAP Intolerance and JHS in FGID and Association With Microbiome, Dyssynergic Defecation and Dietary Intervention"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Functional Gastrointestinal Disorders"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 498,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05298254",
          "briefTitle": "A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Simplex"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 505,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06468527",
          "briefTitle": "Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07057466",
          "briefTitle": "Prospective Evaluation of AI-ECG for SHD Detection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Valvular Heart Disease Stenosis and Regurgitation (Diagnosis)", "Pulmonary Hypertension (Diagnosis)", "Heart Failure With Reduced Ejection Fraction (HFrEF; Diagnosis)", "Heart Failure With Preserved Ejection Fraction (HFpEF; Diagnosis)"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 590,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00373529",
          "briefTitle": "A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-10"
          },
          "completionDateStruct": {
            "date": "2010-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myelogenous Leukemia", "Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 116,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06094270",
          "briefTitle": "Artificial-intelligence-based Reporting Technology for Endoscopy Monitoring and Imaging System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Colonoscopy"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 147,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04366973",
          "briefTitle": "A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction Centers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatitis C Virus (HCV)"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 95,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06638931",
          "briefTitle": "Agnostic Therapy in Rare Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Urachal Cancer", "Parathyroid Carcinoma", "Fibrolamellar Carcinoma", "Angiosarcoma", "Secretory Carcinoma of Breast", "Anal Neoplasms", "Metaplastic Breast Carcinoma", "Translocation Renal Cell Carcinoma", "Carcinosarcoma", "Small Intestine Neoplasms", "Cholangiocarcinoma", "Sertoli-Leydig Cell Tumor", "Adenoid Cystic Carcinoma", "Mesothelioma", "Neuroblastoma", "Adrenal Gland Neoplasms", "Penile Neoplasms", "Apocrine Carcinoma", "Fibrosarcoma", "Cancer of Unknown Primary", "Hemangioblastoma", "Thyroid Neoplasms", "Hepatoblastoma", "Fallopian Tube Neoplasms", "Leiomyosarcoma", "Vaginal Neoplasms", "Neurofibrosarcoma", "Gallbladder Neoplasms", "Osteosarcoma", "Biliary Tract Neoplasms", "Clear Cell Endometrial Cancer", "Yolk Sac Tumor", "Vulvar Neoplasms", "Kaposi Sarcoma", "Ovarian Epithelial Cancer", "Soft Tissue Sarcoma", "Urethral Neoplasms", "Granulosa Cell Tumor", "Primitive Neuroectodermal Tumor", "Neuroendocrine Tumors", "Trophoblastic Tumor"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06625203",
          "briefTitle": "A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Diffuse Large B Cell Lymphoma", "Solid Tumor Cancer"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 7000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07112066",
          "briefTitle": "Multimodality Cardiac Imaging for Disease Progression in ATTR-CM"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Amyloidosis Cardiac"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02513394",
          "briefTitle": "PALbociclib CoLlaborative Adjuvant Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-08"
          },
          "completionDateStruct": {
            "date": "2028-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5796,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05214872",
          "briefTitle": "The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Atherosclerosis of Artery", "Inflammation", "Chronic Kidney Diseases", "Dialysis; Complications", "Cardiovascular Diseases"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 252,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06346977",
          "briefTitle": "Diagnosis of Leptomeningeal Metastasis and the Monitoring of Intrathecal Chemotherapy Efficacy in NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diagnosis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00659425",
          "briefTitle": "CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-09"
          },
          "completionDateStruct": {
            "date": "2014-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Non-Hodgkin's Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 57,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07202117",
          "briefTitle": "PLLA and CaHA-R for Aesthetic Rejuvenation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Aesthetic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "21 Years"
        }
      }
    ],
    "protocolSection.2": [
      {
        "identificationModule": {
          "nctId": "NCT00322348",
          "briefTitle": "Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-04"
          },
          "completionDateStruct": {
            "date": "2009-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 98,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03615040",
          "briefTitle": "Anti-ST2 (MSTT1041A) in COPD (COPD-ST2OP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COPD Exacerbation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02091206",
          "briefTitle": "A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-03-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Epilepsy", "Dravet Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years",
          "maximumAge": "10 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01471847",
          "briefTitle": "A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02"
          },
          "completionDateStruct": {
            "date": "2012-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Locally Advance Breast Cancer (LABC)", "Metastatic Breast Cancer (MBC)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01851733",
          "briefTitle": "MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-08-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Glioblastoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01808326",
          "briefTitle": "A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04"
          },
          "completionDateStruct": {
            "date": "2014-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukaemia, Lymphoblastic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06369285",
          "briefTitle": "A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hormone Receptor Positive HER-2 Negative Breast Cancer", "Metastatic Breast Cancer", "Recurrent Breast Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04513366",
          "briefTitle": "A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Gout"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04546399",
          "briefTitle": "A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Down Syndrome", "Recurrent B Acute Lymphoblastic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 461,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02089763",
          "briefTitle": "Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-04"
          },
          "completionDateStruct": {
            "date": "2017-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatocellular Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05535166",
          "briefTitle": "Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2035-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Medulloblastoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "59 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03735537",
          "briefTitle": "Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Osteogenesis Imperfecta"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 350,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03280563",
          "briefTitle": "A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 144,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03946878",
          "briefTitle": "Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-02-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Blastoid Variant Mantle Cell Lymphoma", "CCND1 Protein Overexpression", "CD20 Positive", "CD5 Positive", "FCER2 Negative", "Pleomorphic Variant Mantle Cell Lymphoma", "Recurrent Mantle Cell Lymphoma", "Refractory Mantle Cell Lymphoma", "t(11;14)(q13;q32)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00835978",
          "briefTitle": "Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-08"
          },
          "completionDateStruct": {
            "date": "2016-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Renal Cell"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 213,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00282048",
          "briefTitle": "Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-03"
          },
          "completionDateStruct": {
            "date": "2009-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Kidney Neoplasms", "Carcinoma, Renal Cell"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02230800",
          "briefTitle": "PPALM-Palm Oil and Pentoxifylline Against Late Morbidity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Long-term Adverse Effects of Radiotherapy for Pelvic Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00071006",
          "briefTitle": "AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-09"
          },
          "completionDateStruct": {
            "date": "2004-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia (AML)", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00932893",
          "briefTitle": "An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09"
          },
          "completionDateStruct": {
            "date": "2016-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Non-Small-Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 347,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04412330",
          "briefTitle": "Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Covid-19", "Critical Illness", "Post Intensive Care Unit Syndrome", "Muscle Weakness"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02855944",
          "briefTitle": "ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ovarian Cancer", "Epithelial Ovarian Cancer", "Fallopian Tube Cancer", "Peritoneal Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 349,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03050268",
          "briefTitle": "Familial Investigations of Childhood Cancer Predisposition"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2037-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Leukemia", "Adenomatous Polyposis", "Adrenocortical Carcinoma", "AML", "BAP1 Tumor Predisposition Syndrome", "Carney Complex", "Choroid Plexus Carcinoma", "Constitutional Mismatch Repair Deficiency Syndrome", "Diamond-Blackfan Anemia", "DICER1 Syndrome", "Dyskeratosis Congenita", "Emberger Syndrome", "Familial Acute Myeloid Leukemia", "Familial Adenomatous Polyposis", "Fanconi Anemia", "Familial Cancer", "Familial Wilms Tumor", "Familial Neuroblastoma", "GIST", "Hereditary Breast and Ovarian Cancer", "Hereditary Paraganglioma-Pheochromocytoma Syndrome", "Hodgkin Lymphoma", "Juvenile Polyposis", "Li-Fraumeni Syndrome", "Lynch Syndrome", "MDS", "Melanoma Syndrome", "Multiple Endocrine Neoplasia Type 1", "Multiple Endocrine Neoplasia Type 2", "Neuroblastoma", "Neurofibromatosis Type 1", "Neurofibromatosis Type II", "Nevoid Basal Cell Carcinoma Syndrome", "Non Hodgkin Lymphoma", "Noonan Syndrome and Other Rasopathy", "Overgrowth Syndromes", "Pancreatic Cancer", "Peutz-Jeghers Syndrome", "Pheochromocytoma/Paraganglioma", "PTEN Hamartoma Tumor Syndrome", "Retinoblastoma", "Rhabdoid Tumor Predisposition Syndrome", "Rhabdomyosarcoma", "Rothmund-Thomson Syndrome", "Tuberous Sclerosis", "Von Hippel-Lindau Disease"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 3000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03604978",
          "briefTitle": "Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Grade 2 Meningioma", "Grade 3 Meningioma", "Recurrent Meningioma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01532089",
          "briefTitle": "Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-03-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["EGFR Exon 19 Deletion Mutation", "EGFR NP_005219.2:p.L858R", "Lung Non-Squamous Non-Small Cell Carcinoma", "Stage IV Lung Non-Small Cell Cancer AJCC v7"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 88,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03069352",
          "briefTitle": "A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia (AML)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 211,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06444750",
          "briefTitle": "Comparison of the Proteome in ICU Patients in Search for TRALI Biomarkers: A Case-control Study Using Both Retrospective and Prospective Samples"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Transfusion-Related Acute Lung Injury", "ARDS, Human"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 210,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05072834",
          "briefTitle": "Identification of Novel Bio-markers for Environmental Enteropathy in Children Using an Evidence Based Approach"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Malnutrition", "Enteropathy"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 380,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "24 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07122271",
          "briefTitle": "Joint Effects of Physical Activity and Diet Quality on Depression and Mortality in Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-07-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Complications", "Depression Anxiety Disorder", "Diabetes"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 3621,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01245062",
          "briefTitle": "GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-12-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 322,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03405818",
          "briefTitle": "An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-10-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-07-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Onychomycosis", "Tinea Unguium"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "72 Months",
          "maximumAge": "203 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07051824",
          "briefTitle": "Probiotic and Prebiotic Use in Early Postoperative Period of Sleeve Gastrectomy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Sleeve Gastrectomy", "Gastrointestinal Symptoms", "Prebiotic", "Probiotic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04381962",
          "briefTitle": "A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 298,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03397108",
          "briefTitle": "Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-11-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Crohn's Disease", "Ulcerative Colitis", "Healthy Controls"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 79,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03126123",
          "briefTitle": "Assessment of the Predictive Value of the Acetic Acid Test in Surgery Condition for the Detection of Dysplastic Lesions in Patients With Anal Condylomatosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-07-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Anal Condyloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 109,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01337687",
          "briefTitle": "Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-10"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Autism Spectrum Disorders"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03420209",
          "briefTitle": "The Effect of Proprioceptive Neuromuscular Facilitation (PNF) Technique for Children With Chronic Pulmonary Diseases."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Respiratory Disease", "Cystic Fibrosis", "Bronchiectasis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "10 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06977828",
          "briefTitle": "A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["NSCLC (Non-small Cell Lung Cancer)", "Neoadjuvant Immunotherapy", "Adjuvant Immunotherapy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03786692",
          "briefTitle": "Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Small Cell Carcinoma of Lung, TNM Stage 4"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 117,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05923112",
          "briefTitle": "BESPONSA Injection 1 mg Special Investigation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Lymphocytic Leukemia"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 421,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "0 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01414855",
          "briefTitle": "A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-08-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-12-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, B-Cell"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05217784",
          "briefTitle": "COVID-19 Antibody Responses in Cystic Fibrosis (CAR-CF)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cystic Fibrosis", "Covid19"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05511012",
          "briefTitle": "Does the Therapist's Assessment of Movement Control in Low Back Pain Patients Correspond to an Objective Kinematic Modification"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Low-back Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01499095",
          "briefTitle": "Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-12"
          },
          "completionDateStruct": {
            "date": "2013-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 811,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05280665",
          "briefTitle": "Specialization in Gastric Cancer Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-03-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Stomach Neoplasms", "Gastric Cancer"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 537,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01458067",
          "briefTitle": "A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-11-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-02-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02661971",
          "briefTitle": "FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Stomach Cancer", "Gastroesophageal Junction Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 180,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06351644",
          "briefTitle": "ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsed and/or Refractory Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00569946",
          "briefTitle": "Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-12-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-10-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Renal Cell"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 64,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03477942",
          "briefTitle": "Impact of Mesenchymal Stem Cells in Knee Osteoarthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Musculoskeletal Pain", "Knee Osteoarthritis", "Cartilage Injury", "Cartilage Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07223892",
          "briefTitle": "Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Wounds", "Venous Leg Ulcers (VLUs)", "Diabetic Foot Ulcers (DFUs)", "Arterial Ulcers", "Pressure Ulcers", "Burn Wounds", "Trauma Wounds", "Surgical Wounds"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 600,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06581848",
          "briefTitle": "Korean Post Marketing Surveillance for ELREXFIO (Elranatamab)."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03541850",
          "briefTitle": "Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["PSA Level Greater Than 0.03", "PSA Progression", "Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7", "Stage II Prostate Adenocarcinoma AJCC v7", "Stage III Prostate Adenocarcinoma AJCC v7"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 92,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04905420",
          "briefTitle": "The Impact of PCCM on Healthcare Among Asthma or Chronic Obstructive Pulmonary Disease (COPD) or Asthma-COPD Overlap Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Asthma", "COPD", "Asthma-COPD Overlap"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 288538,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01432080",
          "briefTitle": "Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-09"
          },
          "completionDateStruct": {
            "date": "2013-12-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Respiratory Tract Infections", "Bronchiolitis Obliterans", "Cryptogenic Organizing Pneumonia", "Lung Diseases, Interstitial"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06118840",
          "briefTitle": "IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Intracranial Aneurysm", "CT Angiography", "Deep Learning", "Double Bind Interaction"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6450,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04771130",
          "briefTitle": "A Study of BGB-11417 in Participants With Myeloid Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-02-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 260,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00258869",
          "briefTitle": "Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-12"
          },
          "completionDateStruct": {
            "date": "2010-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Sepsis", "Septicemia", "Sepsis Syndrome", "Shock, Septic", "Community Acquired Pneumonia"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03034967",
          "briefTitle": "Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-10-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Disease, Chronic Obstructive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 614,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04580836",
          "briefTitle": "MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-17",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Renal Cell Carcinoma", "Stage I Renal Cell Cancer AJCC v8", "Stage II Renal Cell Cancer AJCC v8"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07136974",
          "briefTitle": "Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-08-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Breast Cancer", "HER2 + Breast Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 280,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01119560",
          "briefTitle": "Genetic Susceptibility Biomarkers in Children With Neuroblastoma (Also Known as Neuroblastoma Epidemiology in North America [NENA])"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-02-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neuroblastoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 576,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05561868",
          "briefTitle": "COVID-19 Antibody Responses in Cystic Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cystic Fibrosis", "COVID-19"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04358068",
          "briefTitle": "Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "SARS-CoV 2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04105374",
          "briefTitle": "Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-31",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Anaplastic Astrocytoma", "Glioblastoma", "Oligodendroglioma", "Supratentorial Glioblastoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03520946",
          "briefTitle": "RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 430,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04047173",
          "briefTitle": "RFA Versus SBRT for Recurrent Small HCC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatocellular Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 166,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03744910",
          "briefTitle": "Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Antibody-mediated Rejection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 194,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04724044",
          "briefTitle": "Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Community-acquired Pneumonia", "Sepsis", "Inflammatory Response", "Mortality", "Biomarkers", "SIRS"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 278,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07200947",
          "briefTitle": "A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Non-Small Cell Lung Cancer."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-02-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["SMARCA4-Deficient Tumor", "Locally Advanced or Metastatic Non-Small Cell Lung Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07288502",
          "briefTitle": "Adherence to Secondary Prevention Drugs and Influencing Factors After Acute Coronary Syndrome in Patients at a Tertiary Center in Nepal"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Coronary Syndromes (ACS)", "Adherence"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 109,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02447003",
          "briefTitle": "Study of Pembrolizumab (MK-3475) Monotherapy for Metastatic Triple-Negative Breast Cancer (MK-3475-086/KEYNOTE-086)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-06-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 254,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01777295",
          "briefTitle": "Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-02-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-09-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatitis B"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03643939",
          "briefTitle": "High-Flow Nasal Oxygen Cannula Compared to Non-Invasive Ventilation in Adult Patients With AcuTE Respiratory Failure"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Respiratory Insufficiency", "Respiratory Failure"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1801,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06219083",
          "briefTitle": "Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cancer", "Chemoradiotherapy", "Nutrition, Healthy", "Oncology", "Clinical Outcomes"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1538,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00523341",
          "briefTitle": "Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-08-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-07-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Osteopenia", "Osteoporosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4550,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "60 Years",
          "maximumAge": "94 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01231581",
          "briefTitle": "Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08"
          },
          "completionDateStruct": {
            "date": "2013-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 160,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00876395",
          "briefTitle": "Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 719,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04904107",
          "briefTitle": "Improving the Accuracy of Referrals of Patients With Chest Pain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chest Pain", "Acute Coronary Syndrome", "Myocardial Infarction", "Myocardial Ischemia", "Heart Attack"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 852,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01521416",
          "briefTitle": "Cost of Illness Associated With Influenza in the UK"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-06"
          },
          "completionDateStruct": {
            "date": "2013-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05719259",
          "briefTitle": "Perpetual Observational Study - Ventilator Associated Pneumonia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ventilator Associated Pneumonia"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 20000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06721897",
          "briefTitle": "Effectiveness of a Prehabilitation Program for Hip or Knee Arthroplasty Surgery."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Prehabilitation", "Knee Osteoarthritis", "Hip Osteoarthritis", "Physical Therapy Modalities"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03283774",
          "briefTitle": "Multifactorial Control of Type 2 Diabetes and Treatment Intensity in Primary Care"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01"
          },
          "completionDateStruct": {
            "date": "2017-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300000,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "31 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04992260",
          "briefTitle": "Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11349,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05793008",
          "briefTitle": "Characterization of priMary And sEcondary STress Related takOtsubo"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Takotsubo Cardiomyopathy", "Sepsis-induced Cardiomyopathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02344290",
          "briefTitle": "Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["HIV", "Cardiovascular Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7769,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04913571",
          "briefTitle": "Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-27",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Triple Negative Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 265,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01949116",
          "briefTitle": "Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-12-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 176,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06014255",
          "briefTitle": "Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 219,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05812014",
          "briefTitle": "Clinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) in Participants Aged 18 Years and Older"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "SARS-CoV-2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9800,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04885816",
          "briefTitle": "Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["High Bleeding Risk", "Coronary Artery Disease (CAD)", "Percutaneous Coronary Intervention (PCI)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01799993",
          "briefTitle": "Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-04-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pneumonia, Bacterial"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 725,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03071692",
          "briefTitle": "Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Type2 Diabetes", "Dyslipidemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10544,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00094107",
          "briefTitle": "Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-12"
          },
          "completionDateStruct": {
            "date": "2008-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Melanoma", "Skin Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04127396",
          "briefTitle": "Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Carcinoma, Hepatocellular", "Portal Vein Tumor Thrombus"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01985360",
          "briefTitle": "ISCHEMIA-Chronic Kidney Disease Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01"
          },
          "completionDateStruct": {
            "date": "2020-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cardiovascular Diseases", "Coronary Artery Disease", "Heart Diseases", "Myocardial Ischemia", "Kidney Disease", "End Stage Renal Failure on Dialysis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 777,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01858389",
          "briefTitle": "A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-07"
          },
          "completionDateStruct": {
            "date": "2015-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03594110",
          "briefTitle": "EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6609,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04309617",
          "briefTitle": "Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Cell Carcinoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 618,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04697368",
          "briefTitle": "The Efficacy of Upper Limb Rehabilitation With Exoskeleton in Patients With Subacute Stroke."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-24",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Stroke", "Upper Extremity Paresis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06101589",
          "briefTitle": "Effect of Vitamin D Supplementation on Allostatic Load and Chronic Stress Along Line of Control in Azad Jammu Kashmir"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-09-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Mental Health Issue"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      }
    ]
  }
}
